333 related articles for article (PubMed ID: 7570295)
1. VLA-4 and lymphocyte trafficking in immune-inflammatory states: novel therapeutic approaches in allograft arteriopathy.
Molossi S; Rabinovitch M
Springer Semin Immunopathol; 1995; 16(4):443-65. PubMed ID: 7570295
[No Abstract] [Full Text] [Related]
2. Immunologic factors in transplant arteriopathy: insight from animal models.
Alexis JD; Pyo RT; Chereshnev I
Mt Sinai J Med; 2003 May; 70(3):191-6. PubMed ID: 12764538
[TBL] [Abstract][Full Text] [Related]
3. Coronary arteries from human cardiac allografts with chronic rejection contain oligoclonal T cells: persistence of identical clonally expanded TCR transcripts from the early post-transplantation period (endomyocardial biopsies) to chronic rejection (coronary arteries).
Slachta CA; Jeevanandam V; Goldman B; Lin WL; Platsoucas CD
J Immunol; 2000 Sep; 165(6):3469-83. PubMed ID: 10975868
[TBL] [Abstract][Full Text] [Related]
4. Cytokine profiles as marker for graft vascular disease after clinical heart transplantation.
van Besouw NM; Baan CC; Holweg CT; de Groot-Kruseman HA; Peeters AM; Balk AH; Weimar W
Ann Transplant; 2000; 5(2):61-7. PubMed ID: 11217209
[No Abstract] [Full Text] [Related]
5. The role of histoincompatibility in cardiac allograft vasculopathy.
Costanzo MR
J Heart Lung Transplant; 1995; 14(6 Pt 2):S180-4. PubMed ID: 8719482
[No Abstract] [Full Text] [Related]
6. Identical alpha-chain T-cell receptor transcripts are present on T cells infiltrating coronary arteries of human cardiac allografts with chronic rejection.
Xu B; Sakkas LI; Goldman BI; Jeevanandam V; Gaughan J; Oleszak EL; Platsoucas CD
Cell Immunol; 2003 Oct; 225(2):75-90. PubMed ID: 14698142
[TBL] [Abstract][Full Text] [Related]
7. T cells infiltrating coronary arteries of cardiac allografts with chronic rejection contain clonally expanded T lymphocytes.
Slachta CA; Jeevanandam V; Goldman B; Platsoucas CD
Transplant Proc; 1998 Jun; 30(4):1002-4. PubMed ID: 9636405
[No Abstract] [Full Text] [Related]
8. Natural history of allograft coronary arteriopathy: a retrospective study of 54 patients over a 8 1/2-year period.
Park SJ; Pifarre R; Sullivan H; Montoya A; Kim SY
Cardiovasc Surg; 1996 Feb; 4(1):37-41. PubMed ID: 8634844
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of endothelin expression in allograft coronary arteries after gene therapy targeting Cdk2 kinase.
Isobe M; Suzuki J; Morishita R; Kaneda Y; Sawa Y; Matsuda H; Ogihara T; Horie S; Okubo Y; Amano J
Transplant Proc; 1998 Jun; 30(4):1007-8. PubMed ID: 9636407
[No Abstract] [Full Text] [Related]
10. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
11. Expression of stress proteins and lymphocyte reactivity in heterotopic cardiac allografts undergoing cellular rejection.
Qian J; Moliterno R; Donovan-Peluso MA; Liu K; Suzow J; Valdivia L; Pan F; Duquesnoy RJ
Transpl Immunol; 1995 Jun; 3(2):114-23. PubMed ID: 7582902
[TBL] [Abstract][Full Text] [Related]
12. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
[TBL] [Abstract][Full Text] [Related]
13. Anti-TNF-alpha treatment down-regulates the expression of fibronectin and decreases cellular infiltration of cardiac allografts in rats.
Coito AJ; Binder J; Brown LF; de Sousa M; Van de Water L; Kupiec-Weglinski JW
J Immunol; 1995 Mar; 154(6):2949-58. PubMed ID: 7876561
[TBL] [Abstract][Full Text] [Related]
14. Coronary arteriopathy postcardiac transplant in a heterotopic piglet model: the role of matrix-cytokine interaction.
Clausell N; Coles J; Rabinovitch M
Transplant Proc; 1993 Feb; 25(1 Pt 2):859-60. PubMed ID: 8442248
[No Abstract] [Full Text] [Related]
15. Dual origin of intimal cells in cardiac-allograft arteriosclerosis.
Kennedy LJ; Weissman IL
N Engl J Med; 1971 Oct; 285(16):884-7. PubMed ID: 4939537
[No Abstract] [Full Text] [Related]
16. Cytokine-mediated fibronectin production and transendothelial migration of lymphocytes in the mechanism of cardiac allograft vascular disease: efficacy of novel therapeutic approaches.
Rabinovitch M; Molossi S; Clausell N
J Heart Lung Transplant; 1995; 14(6 Pt 2):S116-23. PubMed ID: 8719473
[No Abstract] [Full Text] [Related]
17. Graft coronary arteriosclerosis in rat heart transplant model with FK 506 short-term administration.
Izutani H; Miyagawa S; Matsumiya G; Nakata S; Shimazaki Y; Matsuda H; Shirakura R
Transplant Proc; 1995 Feb; 27(1):579-81. PubMed ID: 7533425
[No Abstract] [Full Text] [Related]
18. Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts.
Gulizia JM; Kandolf R; Kendall TJ; Thieszen SL; Wilson JE; Radio SJ; Costanzo MR; Winters GL; Miller LL; McManus BM
Am J Pathol; 1995 Aug; 147(2):461-75. PubMed ID: 7639338
[TBL] [Abstract][Full Text] [Related]
19. Cardiac allograft vasculopathy in partially inbred miniature swine. I. Time course, pathology, and dependence on immune mechanisms.
Madsen JC; Sachs DH; Fallon JT; Weissman NJ
J Thorac Cardiovasc Surg; 1996 Jun; 111(6):1230-9. PubMed ID: 8642825
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of graft arterial disease by manipulation of the LIGHT pathway.
Kosuge H; Suzuki J; Kakuta T; Haraguchi G; Koga N; Futamatsu H; Gotoh R; Inobe M; Isobe M; Uede T
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1409-15. PubMed ID: 15178556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
